Pharmaceuticals
FDA advisors vote against effectiveness of Biogen’s ALS drug for rare and aggressive form of the disease
A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration’s independent panel of advisors on Wednesday voted against the effectiveness of Biogen’s investigational ALS drug for a rare and aggressive form of the disease. The drug tofersen […]
Read More
FDA advisors reject Biogen’s ALS drug for rare and aggressive form of the disease
A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration’s independent panel of advisors on Wednesday declined to endorse accelerated approval of Biogen’s investigational ALS drug for a rare and aggressive form of the disease. The drug […]
Read More
View stay: Treasury Secretary Janet Yellen testifies at Senate hearing
(The stream is slated to begin at 2:30 pm ET. Remember to refresh the page if you do not see a online video above at that time.) Treasury Secretary Janet Yellen will testify just before the Senate Appropriations Committee Wednesday, where by she is most likely to deal with rough queries about the federal response […]
Read More
If you had Covid before you were vaccinated, you might have less immunity than you think, study says
A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, U.S., on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images People who caught Covid-19 before they were vaccinated had a weaker immune response to the shots than those who […]
Read More
FDA staff says Biogen’s ALS drug may have a ‘clinical benefit’ on a rare form of the disease
U.S. Food and Drug Administration staff on Monday said Biogen’s investigational ALS drug may have a “clinical benefit” on a rare and aggressive form of the disease, despite failing a broader late-stage clinical trial last year. The staff made the conclusion in briefing documents ahead of a meeting on Wednesday when a panel of external […]
Read More
Biotech company Illumina pushes back against Carl Icahn’s proxy fight over $7.1 billion Grail deal
Carl Icahn Adam Jeffery | CNBC Biotech company Illumina pushed back Monday against Carl Icahn’s proxy fight over the company’s acquisition of cancer test developer Grail, saying the activist investor’s board nominees “do not add value.” The San Diego-based DNA sequencing company released its latest response to Icahn’s sharp criticism of the $7.1 billion deal […]
Read More
Sanofi to slash U.S. insulin prices in 2024 after similar cuts by Eli Lilly and Novo Nordisk
A pharmacist holds a box of the drug Lantus SoloStar, made by Sanofi Pharmaceutical, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters Sanofi on Thursday said it’s planning to cut the U.S. price of its most popular insulin drug by 78% and cap monthly out-of-pocket costs at $35 for people […]
Read More
FDA advisors recommend full approval of Pfizer Covid treatment Paxlovid for adults 50 and over and other high-risk people
Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in boxes, at Misericordia hospital in Grosseto, Italy, February 8, 2022. Jennifer Lorenzini | Reuters The Food and Drug Administration’s independent panel of advisors recommended full approval of Pfizer’s Covid-19 antiviral pill Paxlovid for high-risk adults 16-1 on Thursday, but flagged potentially harmful drug interactions. The treatment […]
Read More
Pfizer will have to pay rebates to Medicare for five drugs under Biden plan to lower Rx costs
President Joe Biden delivers remarks about the Build Back Better legislation’s new rules around prescription drug prices in the East Room of the White House on December 06, 2021 in Washington, DC. Chip Somodevilla | Getty Images Five of Pfizer’s drugs will cost less for Medicare recipients starting next month as part of President Joe […]
Read More
FDA authorizes Pfizer’s Covid omicron booster as fourth shot for kids under 5
A staff member draws up a syringe with the Comirnaty vaccine from Biontech and Pfizer adapted to the Omicron-BA.1 variant at the Mainz vaccination center. Sebastian Christoph Gollnow | dpa | Picture Alliance | Getty Images The U.S. Food and Drug Administration on Tuesday authorized Pfizer’s omicron booster shot for kids under five years old […]
Read More